Search Results - "Lasa-Teja, Carmen"

Clinical and Ultrasound Remission in Rheumatoid Arthritis Patients Treated with JAK Inhibitors: A Real-World Study.

Authors: Lasa-Teja, Carmen Fernández-Cabero, Juan José Sánchez-Bilbao, Lara et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p278. 12p.

Cryofibrinogenemia in PRECOVID-19 and COVID-19 Periods: Single University Study in Northern Spain.

Authors: Sánchez López, María del Amparo Lasa-Teja, Carmen Renuncio-García, Mónica et al.

Source: Sci (2413-4155). Jun2025, Vol. 7 Issue 2, p81-N.PAG. 14p.

Changes in NK Cells and Exhausted Th Cell Phenotype in RA Patients Treated with Janus Kinase Inhibitors: Implications for Adverse Effects.

Authors: Fernández-Cabero, Juan José Lasa-Teja, Carmen San Segundo, David et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5160. 13p.

Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study.

Authors: Lasa-Teja, Carmen Loricera, Javier Prieto-Peña, Diana et al.

Source: Sci (2413-4155). Mar2025, Vol. 7 Issue 1, p12. 14p.

Increased Risk of Herpes Zoster in Rheumatoid Arthritis Not Only Due to JAK Inhibitors—Study of 392 Patients from Single University Center.

Authors: Domínguez-Casas, Lucía C. Lasa-Teja, Carmen Ferraz-Amaro, Iván et al.

Source: Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 11, p3121. 13p.

Abstract Supplement ACR Convergence 2023.

Source: Arthritis & rheumatology Oct2023 Supplement; Vol. 75.

Journal Info: Publisher: Wiley-Blackwell ISSN: 2326-5191

Abstract Supplement ACR Convergence 2022.

Source: Arthritis & rheumatology Sep2022 Supplement 9; Vol. 74.

Journal Info: Publisher: Wiley-Blackwell ISSN: 2326-5191